SHARE

The impact of our high-quality low-cost RNA

Given the advantages of our platform, we aim to make the benefits of RNA, and other biologics, accessible to everyone.

For agriculture, we are developing products that promote sustainability and supplement or replace traditional pesticides and fungicides with RNA in farmers’ crop-protection programs.

In the next five years, our pipeline includes seven agricultural products planned for launch.

We anticipate this pipeline will demonstrate:

  1. Fast development of agricultural products. Our Colorado potato beetle product reaches the market in only five years, roughly half the typical 10‑year agribusiness cycle.
  1. Rapid integration of acquisitions. After acquiring Bayer’s topical RNA honeybee treatment in December 2020, we advanced it through development and secured regulatory approval in September 2025.
  1. Scaled production. Our Rochester RNA pilot facility produces 1,000 kg of dsRNA annually to supply field‑trial samples, while our commercial manufacturing facility delivers 5.2 MT per year with the ability to scale rapidly to more than 50 MT.